Evidence map›Paper›PMID 35172789›Full record

ArticleBMC public health2022

Stakeholders' hopes and concerns about the COVID-19 vaccines in Southeastern Nigeria: a qualitative study.

Uchechukwu Madukaku Chukwuocha, Chiagoziem Ogazirilem Emerole, Greg Ndubeze Iwuoha, Ugonma Winnie Dozie, Princewill Ugochukwu Njoku, Chidinma Onyebuchi Akanazu, Precious Okechukwu Eteike, Charlotte Hemingway

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Views of Nigerian civil servants about compulsory COVID-19 vaccination: A qualitative study.African journal of primary health care & family medicine · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. COVID-19 vaccine hesitancy in Africa: a scoping review.Global health research and policy · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Uchechukwu Madukaku ChukwuochaDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria. uchukwuocha@gmail.com.
Chiagoziem Ogazirilem EmeroleDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Greg Ndubeze IwuohaDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Ugonma Winnie DozieDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Princewill Ugochukwu NjokuDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Chidinma Onyebuchi AkanazuDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Precious Okechukwu EteikeDepartment of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria.
Charlotte HemingwayDepartment of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Federal University of Technology Owerri · NGLiverpool School of Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEquitable access and high uptake of safe and effective vaccines is critical to ending the COVID-19 pandemic. To ensure the success of these vaccines, particularly in many developing and under-developed parts of the world, the concerns of local communities including fears, potency, and levels of acceptance should be addressed. This study assessed community stakeholders' perceptions in parts of Southeastern Nigeria about COVID-19 vaccine, towards engaging them effectively to ensure the success of the vaccination campaigns.

methodsA qualitative study was conducted involving fourteen stakeholders from the Southeastern geo-political zone of Nigeria selected using purposive sampling. In-depth semi-structured individual interviews lasting about 30 min were used to collect data. Data analysis was informed by a general inductive approach.

resultsStakeholders hoped that the development and roll out of the vaccines will bring COVID -19 to an end, will help to maintain good health and allow people get back to normal life. On the other hand, stakeholders expressed their concerns and worries about the "speed" with which the vaccines are being produced, possibility of future adverse effects from vaccination, misinformation, and level of preparedness in the health system to implement the vaccine campaign.

conclusionsThis study identified that more needs to be done to improve perceptions of those who influence health decisions in communities towards COVID-19 vaccines. This includes firstly, the involvement of the community and religious leaders in vaccine promotion. Secondly, it is imperative to develop and disseminate persuasive messaging on vaccine effectiveness and safety targeted at both health professionals, policymakers, and the community which are culturally sensitive and address identified concerns among health workers. Thirdly, the health systems should be strengthened and system-level interventions that directly target one or more of the WHO's six health system building blocks: service delivery, health workforce, health information systems, access to essential medicines, financing, and leadership/governance.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansNigeriaPandemicsSARS-CoV-2VaccinationCOVID-19 VaccinesVaccinesConcernsCOVID – 19HopesSoutheasternNigeriaStakeholdersVaccine

Identifiers

PMID35172789
PMCPMC8848682
OpenAlexW4212790949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.